Journal
CELL DEATH & DISEASE
Volume 4, Issue -, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/cddis.2013.141
Keywords
cannabinoids; THC; JWH-015; PPAR gamma; TRIB3; HepG2
Categories
Funding
- Spanish Ministry of Economy and Compentitivity (Comunidad de Madrid) [BFU2012-31444, CAM S2010/BMD-2308]
- University of Alcala [GC2011-001]
- Spanish Foreign Ministry
Ask authors/readers for more resources
Cannabinoids exert antiproliferative effects in a wide range of tumoral cells, including hepatocellular carcinoma (HCC) cells. In this study, we examined whether the PPAR gamma-activated pathway contributed to the antitumor effect of two cannabinoids, D9-tetrahydrocannabinol (THC) and JWH-015, against HepG2 and HUH-7 HCC cells. Both cannabinoids increased the activity and intracellular level of PPAR gamma mRNA and protein, which was abolished by the PPAR gamma inhibitor GW9662. Moreover, genetic ablation with small interfering RNA (siRNA), as well as pharmacological inhibition of PPAR gamma decreased the cannabinoid-induced cell death and apoptosis. Likewise, GW9662 totally blocked the antitumoral action of cannabinoids in xenograft-induced HCC tumors in mice. In addition, PPAR gamma knockdown with siRNA caused accumulation of the autophagy markers LC3-II and p62, suggesting that PPAR gamma is necessary for the autophagy flux promoted by cannabinoids. Interestingly, downregulation of the endoplasmic reticulum stress-related protein tribbles homolog 3 (TRIB3) markedly reduced PPAR gamma expression and induced p62 accumulation, which was counteracted by overexpression of PPAR gamma in TRIB3-knocked down cells. Taken together, we demonstrate for the first time that the antiproliferative action of the cannabinoids THC and JWH-015 on HCC, in vitro and in vivo, are modulated by upregulation of PPAR gamma-dependent pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available